Arcutis Biotherapeutics, Inc.

8-K Director or officer change; Regulation FD disclosure Jul 16, 2026 8-K Shareholder vote results; Other events Jun 9, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K May 6, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Director or officer change; Regulation FD disclosure Dec 8, 2025 10-Q Quarter ended 2025-09-30 Oct 28, 2025 8-K Results of operations (earnings release) Oct 28, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results; Other events Jun 17, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Director or officer change; Regulation FD disclosure Apr 10, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Results of operations (earnings release) Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q/A Quarter ended 2024-03-31 Jul 24, 2024 8-K Shareholder vote results Jun 18, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 8-K Director or officer change; Regulation FD disclosure Apr 10, 2024 8-K Other events Mar 4, 2024 8-K Entered a material agreement Feb 28, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024 8-K Director or officer change Feb 15, 2024 8-K Other events Jan 11, 2024 8-K Other events Dec 18, 2023 10-Q Quarter ended 2023-09-30 Nov 3, 2023 8-K Results of operations (earnings release) Nov 3, 2023 8-K Other events Oct 23, 2023 8-K Results of operations (earnings release); Other events Oct 19, 2023 8-K Director or officer change; Regulation FD disclosure Sep 27, 2023 10-Q/A Quarter ended 2023-06-30 Sep 15, 2023